Google Custom Search
HIV and AIDS Top News Articles
   
First-line Antiretroviral Therapy for People with HIV Infection
11-17-2009
Posters from the 12th European AIDS Conference Available on HIVandHepatitis.com
11-17-2009
Raltegravir (Isentress), Etravirine (Intelence), and Boosted Darunavir (Prezista) Is Highly Effective for Treatment-experienced Adolescents
11-17-2009
Effect of Obesity on CD4 Cell Count
11-10-2009
International AIDS Society and WHO Urge Universal Access to HIV Therapy for Prevention of Infection as Well as for Treatment
11-10-2009
How Much Ritonavir (Norvir) Is Needed to Boost HIV Protease Inhibitors?
11-6-2009
Mathematical Model Shows Opt-out HIV Testing Would Save Lives
11-6-2009
Bold Efforts to Find a Cure for HIV AIDS and New Prevention Tools Are Urgently Needed, NIAID Director Says
11-6-2009
Raltegravir (Isentress) Has Durable Antiviral Activity and Remains Well-tolerated after 3 Years
11-3-2009
Longer STEP Follow-up Suggests Adenovirus HIV Vaccine Did Not Increase Infection Risk, May Lower Viral Set-point
11-3-2009
President Obama Signs Ryan White Act, HIV Travel and Immigration Ban Will Be Lifted Early Next Year
11-3-2009
Raltegravir (Isentress), Etravirine (Intelence), and Boosted Darunavir (Prezista) Is Effective for Heavily Treatment-experienced Patients
10-30-2009
Three-quarters of HIV Positive Prisoners Decrease Adherence to Antiretroviral Therapy after Release
10-30-2009
Traditional Pap Smears Work as well as ThinPrep Cytology Test for Detecting Precancerous Cervical Cell Changes
10-30-2009
Additional ALVAC/AIDSVAX HIV Vaccine Data Show Only Modest Benefit with Minimal Statistical Significance
10-23-2009
Abacavir (Ziagen) May Contribute to Impaired Endothelial Function in HIV Patients with Suppressed Viral Load
10-23-2009
Does Endothelial Function Decline after Starting Antiretroviral Therapy?
10-23-2009
U.S. House and Senate Pass Ryan White Extension Act, Ensuring Continued HIV/AIDS Funding
10-23-2009
Is It Possible to Eliminate Tuberculosis?
10-23-2009
Does Virological Response to Antiretroviral Therapy Differ between African-American and White HIV Patients?
10-20-2009
Hispanic and Black Patients -- Especially Immigrants -- May Be Less Likely to Achieve Complete HIV Treatment Adherence
10-20-2009
Successful Treatment of Facial Lipoatrophy with a New Formulation of Hyaluronic Acid (Restylane SubQ)
10-20-2009
FDA Approves Gardasil Human Papillomavirus Vaccine for Boys and Young Men, Cervarix for Girls and Young Women
10-20-2009
Analysis of H1N1 Swine Flu Cases in Mexico and Canada Shows Rapid Progression, Young Adults More Likely to Develop Severe Illness
10-20-2009
Raltegravir (Isentress) and Darunavir (Prezista) Appear to Reach Therapeutic Levels in Cerebrospinal Fluid
10-16-2009
Topical Trichloroacetic Acid Is Safe and Effective for Pre-cancerous Anal Lesions in Men with HIV
10-16-2009
Small Molecule Compound 5HN Flushes Out Latent HIV in Reservoir CD4 T-cells
10-16-2009
NIH Starts Trial of H1N1 "Swine" Flu Vaccine in Pregnant Women, Will Soon Study HIV Positive Youth and People with Asthma
10-16-2009
October 15 Is Latino AIDS Awareness Day
10-13-2009
FDA Advisory Committee Recommends Approval of CCR5 Antagonist Maraviroc (Selzentry) for Treatment-naive Patients
10-13-2009
Menopause May Occur Earlier in HIV Positive Women but Does Not Affect Treatment Response
10-13-2009
Latest ADAP Figures Show Increasing Demand and More People on Waiting Lists for HIV Drugs
10-13-2009
Chronic Fatigue Syndrome Linked to Infectious Retrovirus XMRV
10-13-2009
FDA Issues Updates for Health Professionals on Vaccines and Antiviral Medications for H1N1 Influenza (Swine Flu)
10-13-2009
HIV Patients with a CD4 Cell Count Below 500 Cells/mm3 Are at Increased Risk for Cancer
10-09-2009
Meta-Analysis of Truvada vs Epzicom Backbones Used with Boosted Protease Inhibitors for First-line Antiretroviral Therapy
10-09-2009
HIV Positive People Are at Higher Risk for Cancer, especially Malignancies Linked to Infectious Pathogens or Smoking
10-09-2009
Effective Antiretroviral Therapy Leads to Improved Lung Function in People with HIV
10-09-2009
Avexa Closes Trial of Experimental NRTI Apricitabine, Will Evaluate 24-week Data
10-09-2009
FDA Announces Authorization of 100th Generic Antiretroviral Product for Use under PEPFAR
10-09-2009
Boehringer Ingelheim Announces Co-Pay Rebate Program for Nevirapine (Viramune)
10-09-2009
Level of Treatment Adherence Needed to Keep HIV Undetectable May Decline Over Time
10-06-2009
Raltegravir (Isentress), Etravirine (Intelence), and Ritonavir-boosted Darunavir (Prezista) Is a Safe and Successful Salvage Regimen
10-06-2009
Monoclonal Antibody PRO 140 Demonstrates Good Tolerability and Potent Activity against CCR5-tropic HIV
10-06-2009
Variations in "SEVI" Semen Component May Help Explain Racial/ethnic Differences in HIV Transmission Rates
10-06-2009
New Global Report Indicates that More than 4 Million People Worldwide Received Antiretroviral Therapy at the End of 2008
10-06-2009
White House AIDS Office Announces Upcoming National HIV/AIDS Community Discussions
10-06-2009
First Shipments of H1N1 Vaccine Are Released and Oseltamivir (Tamiflu) Distribution Widens as "Swine Flu" Spreads
10-06-2009
Raltegravir (Isentress) plus Atazanavir (Reyataz) Maintenance Therapy Appears Safe and Effective in Small Study
10-02-2009
Short-term Enfuvirtide (Fuzeon) May Promote Long-term CD4 Cell Recovery in Patients Who Start Treatment Late
10-02-2009
People Who Decline Routine HIV Testing Are More Likely to Be Positive; Written Consent Requirement May Discourage Testing
10-02-2009
Senate Committee Unanimously Passes Ryan White HIV/AIDS Funding Extension
10-02-2009
Phase 3 Study in Thailand Shows First Evidence that HIV Vaccine Can Reduce Rate of Infection
9-25-2009
HIV Maturation Inhibitor Bevirimat Demonstrates Promising Safety and Efficacy in Patients with Responsive HIV Genotype
9-25-2009
Sunday is National Gay Men's HIV/AIDS Awareness Day
9-25-2009
FDA Approves New Abbott Prism Automated Test for Screening Donated Blood and Organs for HIV
9-25-2009
SB 486 Would Make Safe Needle Disposal a Shared Responsibility
9-25-2009
Early Studies Demonstrate Potent Activity and Safety of Experimental Integrase Inhibitor S/GSK1265744
9-22-2009
Once Daily Raltegravir (Isentress) Shows Promise in Pilot Study
9-22-2009
Nevirapine (Viramune) and Boosted Atazanavir (Reyataz) Produce Comparable Early Virological and Immunological Response
9-22-2009
Nutritional Formula Reduces CD4 Cell Decline in HIV Positive People Not Yet Taking Antiretroviral Therapy
9-22-2009
New Injectable Drug Peramivir Is as Effective as Oseltamivir (Tamiflu) for Seasonal Influenza
9-22-2009
New Clinical Trial Tests Tenofovir Vaginal Gel and Truvada Tablets as HIV Prevention Strategy for Women in Africa
9-22-2009
Current Guidelines Need to Be Changed for Both First-line Treatment and Re-treatment of Tuberculosis, Experts Say
9-18-2009
European Commission Approves Raltegravir (Isentress) and Once-daily Lopinavir/ritonavir (Kaletra) for First-Line HIV Therapy
9-18-2009
IL-7 Improves CD4 and CD8 T-Cell Recovery among HIV Patients on Suppressive Antiretroviral Therapy
9-18-2009
GRACE Trial shows Women Respond as well as Men to Etravirine (Intelence), but Blacks May Have Poorer Outcomes than Whites
9-18-2009
FDA Approves Four Vaccines for 2009 H1N1 Influenza (Swine Flu) Virus
9-18-2009
CCR5 Antagonist Vicriviroc Demonstrates Long-Term Safety and Efficacy at 96 Weeks
9-15-2009
At 96 Weeks, Raltegravir (Isentress) Is as Effective as Efavirenz (Sustiva) in Suppressing HIV Viral Load and Improving Immune Function
9-15-2009
Tobacco and Marijuana May Significantly Lower Atazanavir (Reyataz) Blood Levels
9-15-2009
Antiretroviral Pregnancy Registry Indicates Use of Tenofovir (Viread) by Pregnant Women Does Not Raise Risk of Birth Defects
9-15-2009
Study Shows Strong Immune Response after a Single Dose of Vaccine for 2009 H1N1 Influenza A ("Swine Flu")
9-15-2009
NIH Statement on Preliminary Results from Clinical Trials of H1N1 Influenza Vaccines
9-15-2009
H1N1 "Swine Flu" Epidemic in the U.S. May Peak before Adequate Supplies of Vaccine Become Available
9-15-2009
AIDS Activists Issue Grades to Drug Companies
9-11-2009
HIV Infection Sharply Increases Risk of Atherosclerosis, but Antiretroviral Therapy Has a Minor Effect
9-11-2009
Artery Elasticity Is Reduced in People with Untreated HIV Infection
9-11-2009

Newly Discovered Neutralizing Antibodies Suggest Novel HIV Vaccine Approach
9-11-2009